'Quick, Affordable' Test Helps Predict CGRP Response for Migraine

Testing for nonictal cephalic allodynia can help determine with high accuracy which migraine patients will (and which will not) respond to treatment with the anti-CGRP agent galcanezumab.
Medscape Medical News

source https://www.medscape.com/viewarticle/988530?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?